Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12015-020-09994-5 http://scihub22266oqcxt.onion/10.1007/s12015-020-09994-5 32564256!7305935!32564256     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stem+Cell+Rev+Rep 2021 ; 17 (1): 163-175 Nephropedia Template TP {{tp|p=32564256|t=2021. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises |pdf=|usr=}}{{32564256}} gab.com Text Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises JO: Stem Cell Rev Rep http://www.kidney.de/pget.php?&tw=1&pmid=32564256 #FOAvip Novel coronavirus disease (COVID-19) has attracted much attention around the world due to its rapid transmission among humans and relatively high mortality rate. Studies are increasing to find the best therapeutic approach for the disease and its management. Regenerative medicine offers various cell-tissue therapeutics and related products, such as stem cell therapy, natural killer (NK) cell therapy, Chimeric antigen receptor (CAR) T cell therapy, exosomes, and tissue products. Interestingly, mesenchymal stem cells (MSCs) can reduce inflammatory symptoms and protect against cytokine storm, which critically contributes to the COVID-19 progression. Notably, having the potentials to exert cytotoxic effects on infected cells and induce interferon production probably make NK cells a candidate for COVID-19 cell therapy. Besides, exosomes are one of the crucial products of cells that can exert therapeutic effects through the induction of immune responses and neutralizing antibody titers. The paper aims to briefly consider current options for COVID-19 therapy to show that there is no specific cure for COVID-19, and then assess the real opportunities and range of promises regenerative medicine can provide for specific treatment of COVID-19. Graphical Abstract Therapeutic Potential of Regenerative Medicine against COVID19. Twit Text FOAVip Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises ????Stem Cell Rev Rep http://www.kidney.de/pget.php?&tw=1&pmid=32564256 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32564256 #FOAvip English Wikipedia <ref>{{Cite pmid|32564256}}</ref> Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises #MMPMID32564256 Basiri A; Pazhouhnia Z; Beheshtizadeh N; Hoseinpour M; Saghazadeh A; Rezaei N Stem Cell Rev Rep 2021[Feb]; 17 (1): 163-175 PMID32564256show ga Novel coronavirus disease (COVID-19) has attracted much attention around the world due to its rapid transmission among humans and relatively high mortality rate. Studies are increasing to find the best therapeutic approach for the disease and its management. Regenerative medicine offers various cell-tissue therapeutics and related products, such as stem cell therapy, natural killer (NK) cell therapy, Chimeric antigen receptor (CAR) T cell therapy, exosomes, and tissue products. Interestingly, mesenchymal stem cells (MSCs) can reduce inflammatory symptoms and protect against cytokine storm, which critically contributes to the COVID-19 progression. Notably, having the potentials to exert cytotoxic effects on infected cells and induce interferon production probably make NK cells a candidate for COVID-19 cell therapy. Besides, exosomes are one of the crucial products of cells that can exert therapeutic effects through the induction of immune responses and neutralizing antibody titers. The paper aims to briefly consider current options for COVID-19 therapy to show that there is no specific cure for COVID-19, and then assess the real opportunities and range of promises regenerative medicine can provide for specific treatment of COVID-19. Graphical Abstract Therapeutic Potential of Regenerative Medicine against COVID19. |*Cell- and Tissue-Based Therapy[MESH] |*Mesenchymal Stem Cell Transplantation[MESH] |COVID-19/*therapy/virology[MESH] |Coronavirus Infections/*therapy/virology[MESH] |Exosomes/immunology[MESH] |Humans[MESH] |Mesenchymal Stem Cells/immunology[MESH] |Regenerative Medicine[MESH]Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Ra(epmc).pdf DeepDyve Pubget Overpricing